Stock Market News
Alliance Pharma wins £5m compensation from Sinclair Pharma
AIM-listed Alliance Pharma has gained £5m in compensation from Sinclair Pharma in connection to a sales-shortfall of Kelo-stretch, a cream that treats stretch marks, which it bought in December 2015 as part of its acquisition of Sinclair's healthcare products business.
The £5m compensation, which the company will use to reduce its loans, consists of £4m to be paid by 30 April and £1m to be paid by 30 June 2018.
Sinclair has also relinquished all US rights to Flammacerium, a drug to treat infections and severe burns, with immediate effect to Alliance.
As part of the acquisition of Sinclair's healthcare business, Sinclair had retained royalty rights for Flammacerium in the US but has now relinquished these as part of the compensation package to Alliance.
The company said that it is currently registering Flammacerium in the US and plans to seek registration guidance from the US regulatory authority in the second half of 2017.
Flammacerium is currently available to treat severe burns and for wound management in Europe.
Chief executive John Dawson said that the £5m compensation was "fair" and that the US rights to Flammacerium provides the company with an additional opportunity which it is now exploring.
He added: "Overall, the acquisition of Sinclair's healthcare products business in December 2015 has been transformational for Alliance, bringing some key growth products into the company's portfolio and increasing our scale and international reach."
Shares in Alliance Pharma were up 1.49% to 47.70p at 0845 GMT.
The £5m compensation, which the company will use to reduce its loans, consists of £4m to be paid by 30 April and £1m to be paid by 30 June 2018.
Sinclair has also relinquished all US rights to Flammacerium, a drug to treat infections and severe burns, with immediate effect to Alliance.
As part of the acquisition of Sinclair's healthcare business, Sinclair had retained royalty rights for Flammacerium in the US but has now relinquished these as part of the compensation package to Alliance.
The company said that it is currently registering Flammacerium in the US and plans to seek registration guidance from the US regulatory authority in the second half of 2017.
Flammacerium is currently available to treat severe burns and for wound management in Europe.
Chief executive John Dawson said that the £5m compensation was "fair" and that the US rights to Flammacerium provides the company with an additional opportunity which it is now exploring.
He added: "Overall, the acquisition of Sinclair's healthcare products business in December 2015 has been transformational for Alliance, bringing some key growth products into the company's portfolio and increasing our scale and international reach."
Shares in Alliance Pharma were up 1.49% to 47.70p at 0845 GMT.
Related share prices |
---|
Alliance Pharma (APH) share price |
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- RBS share price
- Diageo share price
- Standard Life Share Price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- Morrisons Share Price
- Aviva Share Price
- ASOS Share price
- RPT Share Price
- SXX Share Price
- Easyjet Share Price
- Next Share Price
- Thomas Cook Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- Greene King Share Price
- Marstons share price
- NUOG share price
- UKOG share price
- SOLG share price